Latest News
CAR-T Therapy Explained: A Plain-English Guide
CAR-T therapy is one of the most discussed cancer treatments of the past decade, and one of the most widely misunderstood. The name is an acronym. The science involves genetic engineering. The price runs to hundreds of thousands of pounds per patient. This guide...
Latest News
Daraxonrasib FDA Filing: What Happens Next for Pancreatic Cancer Patients?
The daraxonrasib FDA filing is nearing completion, marking a pivotal regulatory moment for patients with metastatic pancreatic ductal adenocarcinoma (PDAC). Revolution Medicines announced on 7 July 2026 that its rolling submission of a New Drug Application (NDA) to...
Digital Twin: The Future of Pharmaceutical Manufacturing Science
Pharmaceutical manufacturing is entering a new scientific era. For decades, the industry has relied on validated processes, fixed control strategies, laboratory testing and carefully documented batch records to prove that medicines are made consistently and safely....
How AI-Enabled Functional Precision Oncology Is Personalizing Treatment
When the Standard Playbook Runs Out In pediatric and adult oncology alike, there is a recognizable moment when the standard treatment playbook is exhausted. For patients with rare, relapsed, or treatment-resistant cancers, guidelines built for the common case offer...
The Infrastructure Gap Behind the GLP-1 Boom
The rapid rise of GLP-1 medications has transformed healthcare delivery in ways few therapeutic categories have achieved in recent decades. Originally developed to help manage type 2 diabetes, GLP-1 receptor agonists such as semaglutide and tirzepatide have become...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
Why a New Era of Medical Innovation is Taking Shape
Over the next decade, modern medicine is poised to undergo a redefinition that has not been seen in generations. The surge in innovation, transformational scientific discoveries and rapidly maturing technologies is redefining patient outcomes. The biotech industry is...
Activating Autophagy, Your Body’s Natural Metabolic Superpower
Did you know that your body has its own biological process for clearing out old or damaged cells, and recycling dysfunctional components to prioritize healthier, more productive ones? For billions of years, autophagy has acted as a kind of evolutionary survival...
Beyond the Basics: How Behavioral Intelligence and ML Reduce Trial Dropout
Medication non-adherence and dropout have long been labeled “known problems” in the clinical trial space. Yet despite years of tinkering with the formula, these challenges have only become “well-known problems.” Operational efficiencies and innovation, digital...
Why Health Platforms Built for Millennials Will Fail Gen Alpha
The first smartphone-native generation expects fundamentally different things from digital health and retrofitting won't work Gen Alpha (born roughly between 2010 and 2024) is the first generation to grow up entirely in a world where smartphones, AI assistants, and...
Summary: England Rare Diseases Action Plan 2026
The England Rare Diseases Action Plan 2026 outlines how the Department of Health and Social Care and partner organisations are delivering commitments under the UK Rare Diseases Framework to improve outcomes for people living with rare conditions in England. The report...
A Decentralized Advantage: Outpatient Theranostics is the Clinical Standard
While oncology has historically relied on a "Hospital-as-Hub" model, the specific logistical demands of radiopharmaceutical therapy (RPT) are revealing its limitations. The decentralized outpatient model is emerging as a significant industry trend, demonstrating that...
Why Patent Portfolios are Crucial for Life Science Innovators
In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their innovations by implementing a strategic intellectual...
The Convergence Era: How Data and AI are Reshaping Life Sciences
For decades, innovation in life sciences followed a familiar path: lab discovery, clinical testing, regulatory approval, market release. It was linear. Predictable. Slow. What’s happening now feels different. The most significant shift isn’t a single breakthrough...
Atomic Warriors: How Structural Biology is Decoding the Next Pandemic
As the echoes of the COVID-19 crisis fade, humanity remains on high alert for the inevitable next pathogen. What if we could dissect viruses down to their atomic core, revealing chinks in their armor that lead to revolutionary treatments? Drawing from my 12+ years as...
Life Science and Biopharma in 2026: Insights from L.E.K. Consulting
The biopharma industry is at an inflection point as it enters 2026. Discoveries from the past year will be applied and scaled, particularly across AI-enabled drug development, advanced modalities and cardiometabolic disease treatment. These advancements will occur...
ESGO 2026: Elenagen Phase II Data in Platinum-Resistant OC
At the 2026 Congress of the European Society of Gynaecological Oncology (ESGO) in Copenhagen, Dr Gabriel Levin of the McGill University Health Centre will present Phase II data evaluating the investigational DNA therapy Elenagen in combination with gemcitabine for...
Global Funding Shifts Redraw Life Sciences Innovation Map
The life sciences sector is experiencing a fundamental reshaping of its innovation geography as funding pressures, policy shifts, and geopolitical tensions redraw the competitive landscape across continents. While research funding constraints in the United States...
Why a New Era of Medical Innovation is Taking Shape
Over the next decade, modern medicine is poised to undergo a redefinition that has not been seen in generations. The surge in innovation, transformational scientific discoveries and rapidly maturing technologies is redefining patient outcomes. The biotech industry is...
Activating Autophagy, Your Body’s Natural Metabolic Superpower
Did you know that your body has its own biological process for clearing out old or damaged cells, and recycling dysfunctional components to prioritize healthier, more productive ones? For billions of years, autophagy has acted as a kind of evolutionary survival...
Beyond the Basics: How Behavioral Intelligence and ML Reduce Trial Dropout
Medication non-adherence and dropout have long been labeled “known problems” in the clinical trial space. Yet despite years of tinkering with the formula, these challenges have only become “well-known problems.” Operational efficiencies and innovation, digital...
Why Health Platforms Built for Millennials Will Fail Gen Alpha
The first smartphone-native generation expects fundamentally different things from digital health and retrofitting won't work Gen Alpha (born roughly between 2010 and 2024) is the first generation to grow up entirely in a world where smartphones, AI assistants, and...
Summary: England Rare Diseases Action Plan 2026
The England Rare Diseases Action Plan 2026 outlines how the Department of Health and Social Care and partner organisations are delivering commitments under the UK Rare Diseases Framework to improve outcomes for people living with rare conditions in England. The report...
A Decentralized Advantage: Outpatient Theranostics is the Clinical Standard
While oncology has historically relied on a "Hospital-as-Hub" model, the specific logistical demands of radiopharmaceutical therapy (RPT) are revealing its limitations. The decentralized outpatient model is emerging as a significant industry trend, demonstrating that...
Why Patent Portfolios are Crucial for Life Science Innovators
In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their innovations by implementing a strategic intellectual...
The Convergence Era: How Data and AI are Reshaping Life Sciences
For decades, innovation in life sciences followed a familiar path: lab discovery, clinical testing, regulatory approval, market release. It was linear. Predictable. Slow. What’s happening now feels different. The most significant shift isn’t a single breakthrough...
Atomic Warriors: How Structural Biology is Decoding the Next Pandemic
As the echoes of the COVID-19 crisis fade, humanity remains on high alert for the inevitable next pathogen. What if we could dissect viruses down to their atomic core, revealing chinks in their armor that lead to revolutionary treatments? Drawing from my 12+ years as...
Life Science and Biopharma in 2026: Insights from L.E.K. Consulting
The biopharma industry is at an inflection point as it enters 2026. Discoveries from the past year will be applied and scaled, particularly across AI-enabled drug development, advanced modalities and cardiometabolic disease treatment. These advancements will occur...
ESGO 2026: Elenagen Phase II Data in Platinum-Resistant OC
At the 2026 Congress of the European Society of Gynaecological Oncology (ESGO) in Copenhagen, Dr Gabriel Levin of the McGill University Health Centre will present Phase II data evaluating the investigational DNA therapy Elenagen in combination with gemcitabine for...
Global Funding Shifts Redraw Life Sciences Innovation Map
The life sciences sector is experiencing a fundamental reshaping of its innovation geography as funding pressures, policy shifts, and geopolitical tensions redraw the competitive landscape across continents. While research funding constraints in the United States...
Featured Articles
Further News
MSD Reorganises to Shield Growth from Impending “Keytruda Cliff”
In its most significant structural overhaul since the 2021 Organon spin-off, MSD (known as Merck & Co. in the U.S. and Canada) has announced the division of its Human Health business into two standalone units: an Oncology Business Unit and a Specialty, Pharma...
Five Big Shifts Redefining the Future of Cell and Gene Therapy
Marking its success San Diego debut earlier this month, Phacilitate’s Advanced Therapies Week (ATW), brought together leaders, innovators, and industry stakeholders from around the world for a dynamic showcase of progress in cell and gene therapies (CGT). From...
Paving the Way in Telomere Biology: The Research of Dr. Kelly Nguyen
Kelly Nguyen is a molecular biologist and Group Leader in the Structural Studies Division at the MRC Laboratory of Molecular Biology (LMB), where her research aims to uncover how telomeres are structured, maintained and regulated by the enzyme telomerase. Telomeres...
Medical Bankruptcy: The Hidden Cost of U.S. Health Care
My wife underwent major surgery in December 2025. She remained 10 days in a Charlotte, NC, hospital and was then for several weeks supported at home by visiting nurses, a physical therapist and a dietician. We just saw the bill: The hospital and participating doctors...
Breaking Silos: How AI Agents are Standardizing Drug Discovery
In the pharmaceutical industry, the statistics of failure are so familiar they have become clichés: it takes ten years and two billion dollars to bring a new drug to market, with a failure rate in clinical trials hovering near 90%. While much of this attrition is...
Cardiac Screening Saves Lives: A Decade of Data and the Case for Change
Dr Steven Cox, CEO of the research charity, Cardiac Risk in the Young (CRY) explains the key findings and importance of a seminal study (reviewing cardiac screening data collated over a 10 year period), published on 24 February 2026 in the Journal of the American...
Pregnancy, the Brain, and the Nervous System
Pregnancy, the Brain, and the Nervous System: A Holistic Perspective on Perinatal Mental Health Pregnancy is often framed as a joyful milestone, yet from a clinical and neurobiological standpoint, it is one of the most significant periods of transformation a human...
Australian Healthcare Reviews Mean Nothing Without the Right Governance
Australians are making some of their most important healthcare decisions based on information that was never designed to carry that weight. For most Australians, searching for health information online and accessing test results digitally is already routine. Around 90...
GMCA: Why Unlocking Longevity Research Will Drive Innovation
The science of longevity has never been more active. With advances in preventive medicine and digital health, as well as new insights into lifestyle, environment, drug therapies and genetics, there is more research available than ever on how people age and live well....
Understanding GLP-1 Side Effects Through a Nutritional Lens
GLP-1 medications have changed the landscape of weight management. For many people, they have delivered clinically meaningful weight loss alongside improvements in glycaemic control, and their place in treatment pathways is now well established. What is becoming...
PICTURE: Democratising Clinical Intelligence from the Frontline
A New Era for EHR Data A new study published in the latest issue of the Royal College of Physicians’ Future Healthcare Journal introduces PICTURE, an innovative data platform designed to convert routine electronic health record (EHR) data into actionable clinical...
European Life Sciences: Rethinking the “Organic” US Expansion
Against a backdrop of rising development and launch costs, growing regulatory complexity, geopolitical uncertainty and intensifying competition for specialist talent, many European pharma and biotech companies are reassessing the long-held ambition of “cracking the...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.